The calcium-independent mannose-6-phosphate (M6P) receptor IGF2R is responsible for the vesicular transport of over 70 hydrolases with M6P domains from TGN and plasma membrane to the lysosome, enabling enzyme replacement therapies for BD [3] and other lysosomal storage diseases. Here, IGF2R is linked to lysosomal storage disease.